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Research
The incidence of testicular germ cell tumors 
(TGCTs) has risen considerably in Caucasian 
populations for more than three decades and 
is now the most commonly diagnosed malig-
nancy among men 15–34 years of age (Purdue 
et al. 2005). TGCTs can be grouped histo-
logically into seminomas and non  seminomas. 
Seminomas are less aggressive than non-
seminomas and peak in incidence at an older age   
(35–40 years vs. 25–30 years) (Moller 1993).
No adequate explanations for the 
remarkable increase in TGCT incidence 
have been identified, as the etiology of this 
cancer remains largely unknown. The only 
well-described risk factors are cryptorchid-
ism, Caucasian ethnicity, and personal and 
family history of TGCT (McGlynn 2001). 
Epidemiologic findings suggest various fac-
tors that may influence TGCT develop-
ment, including exposure to high maternal 
estrogen levels in utero, low androgen levels, 
mechanisms under  lying infertility, and factors 
operating in peri  natal life (McGlynn 2001). 
However, these hypotheses remain tentative.
The hypothesized role of sex hormones in 
testicular carcinogenesis has led to considerable 
interest as to whether exposure to environ-
mental endocrine-disrupting chemicals such 
as organochlorine (OC) compounds may be 
associated with TGCT risk. OC compounds 
are synthetic chemicals used as pesticides and 
in various industrial applications until con-
cerns over their extreme environmental per-
sistence and possible health effects led many 
countries to ban their production and/or use 
in the 1970s and 1980s. Experimental find-
ings suggesting that OC compounds exert 
weak estrogenic, anti  estrogenic, and anti-
androgenic effects (Bonefeld-Jorgensen et al. 
2001; Danzo 1997; Kelce et al. 1995) have 
raised concern over their potential to influ-
ence the develop  ment of TGCTs and other 
male reproductive dis  orders speculated to be 
part of the testicular dysgenesis syndrome: 
cryptorchism, hypospadias, and impaired 
spermatogenesis (Skakkebaek et al. 2001; 
Toppari et al. 1996).
Three case–control studies have investi-
gated the association between serum OC con-
centrations and TGCT risk to date. In a small 
hospital-based study (58 cases, 61 controls) 
conducted in Sweden, investigators found 
significantly higher serum concentrations of 
cis-nonachlor, a congener of the insecticide 
chlordane, among cases compared with con-
trols (Hardell et al. 2003). In addition, moth-
ers of cases were found to have higher serum 
levels of chlordane compounds (cis-nonachlor, 
trans-nonachlor, total chlordanes), the insec-
ticide hexachlorobenzene (HCB), and poly-
chlorinated biphenyls (PCBs)—chemicals 
used in a variety of industrial applications—
than control mothers. The U.S. Servicemen’s 
Testicular Tumor Environmental and 
Endocrine Determinant (STEED) Study, a 
large case–control investigation of TGCTs 
(754 cases, 928 controls) conducted among 
U.S. servicemen, similarly found elevated pre-
diagnostic concentrations of cis-nonachlor, 
trans-nonachlor, and the insecticide metabo-
lite p,p´-dichlorodiphenyldichloroethylene 
(p,p´-DDE) among cases versus controls 
(McGlynn et al. 2008). However, a recent 
population-based study (246 cases, 630 con-
trols) conducted in Washington State observed 
no evidence of association with OC com-
pounds (Biggs et al. 2008). Findings from 
studies of cryptorchidism and hypospadias 
do not support an association with OC com-
pounds (Bhatia et al. 2005; Damgaard et al. 
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ba c K g r O u n D: Recent findings suggest that exposure to organochlorine (OC) compounds, 
  chlordanes and p,p´-dichlorodiphenyldichloroethylene (p,p´-DDE) in particular, may increase the 
risk of developing testicular germ cell tumors (TGCTs).
Ob j e c t i v e: To further investigate this question, we conducted a nested case–control study of 
TGCTs within the Norwegian Janus Serum Bank cohort.
Me t h O D s : The study was conducted among individuals with serum collected between 1972 and 
1978. TGCT cases diagnosed through 1999 (n = 49; 27–62 years of age at diagnosis) were identi-
fied through linkage to the Norwegian Cancer Registry. Controls (n =51) were matched to cases on 
region, blood draw year, and age at blood draw. Measurements of 11 OC insecticide compounds 
and 34 polychlorinated biphenyl (PCB) congeners were performed using gas chromatography/high-
reso  lu  tion mass spectrometry. Case–control comparisons of lipid-adjusted analyte concentrations 
were performed using the Wilcoxon signed-rank test. Odds ratios (ORs) and 95% confidence inter-
vals (CIs) for tertiles of analyte concentration were calculated using conditional logistic regression.
re s u l t s: TGCT cases had elevated concentrations of p,p´-DDE (tertile 3 vs. tertile 1 OR (ORT3) 2.2; 
95% CI, 0.7–6.5; pWilcoxon = 0.07), oxychlordane (ORT3 3.2; 95% CI, 0.6–16.8; pWilcoxon = 0.05), 
trans-nonachlor (ORT3 2.6; 95% CI, 0.7–8.9; pWilcoxon = 0.07), and total chlordanes (ORT3 2.0; 
95% CI, 0.6–7.2; pWilcoxon = 0.048) compared with controls, although no ORs were statistically 
significant. Seminoma cases had significantly lower concentrations of PCB congeners 44, 49, and 52 
and significantly higher concentrations of PCBs 99, 138, 153, 167, 183, and 195.
cO n c l u s i O n s: Our study provides additional but qualified evidence supporting an association 
between exposures to p,p´-DDE and chlordane compounds, and possibly some PCB congeners, and 
TGCT risk.
Key w O r D s : chlordanes, organochlorine compounds, polychlorinated biphenyls, p,p´-dichloro-
diphenyl  dichloroethylene, testicular germ cell tumors. Environ Health Perspect 117:1514–1519 
(2009).  doi:10.1289/ehp.0800359 available via http://dx.doi.org/ [Online 20 May 2009]Organochlorines and testicular germ cell tumors
Environmental Health Perspectives  •  v o l u m e  117 | n u m b e r 10 | October 2009  1515
2006; Flores-Luevano et al. 2003; Longnecker 
et al. 2002; Waliszewski et al. 2005).
We conducted a nested case–control 
within the Janus Serum Bank cohort of 
Norway, the country with the highest inci-
dence of TGCTs in the world (Curado et al. 
2007), to further investigate whether serum 
levels of 11 OC insecticide compounds and 
34 PCB congeners are associated with risk of 
this cancer.
Methods
Study population. The Janus Serum Bank (The 
Cancer Registry of Norway, Oslo, Norway) 
was established in 1972 and consists of speci-
mens from two sources: participants in routine 
county health examinations in selected coun-
ties of Norway, and Red Cross donors (Jellum 
et al. 1995). Blood samples were obtained 
from approximately 264,000 health examina-
tion donors recruited from Finnmark, Oslo, 
Sogn og Fjordane, Oppland (n = 87,647; 
enrolled between 1974 and 1977), and other 
areas in Norway (n = 176,881; recruited 
between 1985 and 1991). Age at entry was 
between 20 and 49 years, with the majority of 
subjects enrolled between 35 and 49 years of 
age. Approximately 29,000 Red Cross donors, 
20–65 years of age at entry and primarily 
from the Oslo region, were enrolled between 
1972 and 1989. Serum from all participants 
was separated and stored at –25°C.
Cases and controls were selected among 
Janus cohort members with the following 
characteristics: no prior history of cancer 
(except non  melanoma skin cancer) at base-
line blood collection; baseline blood col-
lection between 1972 and 1978; and at 
least 0.8 mL of stored serum. TGCT cases 
diagnosed between enrollment through 
31 December 1999 were identified though 
linkage with the Norwegian Cancer Registry, 
using the Norwegian population identifica-
tion number. Of the 61 identified cases, two 
were excluded from further analysis on the 
basis of pathology (one case of spermato  cytic 
seminoma, a rare subtype of TGCT arising 
among older adults, and one case of testicular 
mesothelioma). 
One male control was matched to each case 
by region, time period of blood draw (1-year 
strata), and age group at blood draw (2-year 
strata). Controls were required to be cancer-free 
during the blood draw-to-diagnosis window of 
the respective case (specifically, within the same 
2-year stratum starting from the mid  point of 
the case’s blood draw stratum). To increase sta-
tistical power, we also included four additional 
controls from another project within the Janus 
cohort that was assayed in parallel with the 
TGCT samples at the same laboratory. These 
four controls met the aforementioned match-
ing criteria for—and were in the same assay 
batch as—four cases.
The serum samples of 10 cases and 12 con-
trols were not successfully analyzed because of 
laboratory equipment malfunction or tech-
nician error, leaving 49 case–control pairs 
(49 cases, 51 controls) with organochlorine 
measurements available for analysis.
Demographic and other data were 
obtained from the Norwegian Cancer Registry 
and census, as well as from the Janus cohort 
database containing information from the 
original health examinations and other sur-
veys. In particular, information on height and 
body mass index (BMI) at the time of blood 
collection was available for the subset of sub-
jects who had entered the Janus cohort as a 
result of their participation in routine county 
health examinations (34 cases, 37 controls).
Laboratory analyses. Concentrations of 
11 organochlorine pesticides, their metabolites, 
or related chemicals [β-hexachloro  cyclohexane 
(β-HCH), dieldrin, γ-HCH, HCB, mirex, 
o,p´-DDT, p,p´-DDE, p,p´-DDT, heptachlor 
epoxide, oxy  chlordane, trans-nonachlor] 
and 34 PCB congeners (PCBs 18, 28, 44, 
49, 52, 66, 74, 87, 99, 101, 118, 128, 138, 
146, 149, 151, 153, 156, 157, 167, 170, 
172, 177, 178, 180, 183, 187, 189, 194, 195, 
196, 201, 206, 209; International Union of 
Pure and Applied Chemistry) and lipid lev-
els were measured at the Centers for Disease 
Control and Prevention, National Center 
for Environmental Health in 0.7 mL serum, 
using previously published methods (Engel 
et al. 2007). In brief, serum samples were first 
spiked with isotopically labeled internal stan-
dards, then purified via automated accelerated 
solvent extraction and high-resolution gel per-
meation chromatography on a high-perfor-
mance liquid chromatograph. Concentrated 
extracts were analyzed by gas chromatography/
high-resolution mass spectrometry. Selected 
PCB congeners and organochlorine pesticides 
in each sample were quantified from 13C iso-
tope dilution continuing calibration plots, 
which automatically corrected for extraction 
efficiency. Values below the instrumental lim-
its of detection (LOD) were imputed using 
a parametric model-based estimation proce-
dure (Lubin et al. 2004). Using measurements 
among controls for a target analyte, we used 
maximum likelihood methods to estimate 
parameters for the log-normal distribution. 
For each measurement < LOD, we randomly 
sampled a value from the appropriate log-
normal distribution as the imputed value. As 
a quality control check for possible errors in 
measurement due to interfering compounds, 
the ratio of 35Cl to 37Cl was calculated for 
each analyte and compared with the expected 
ratio for that analyte. Analyte measurements 
with observed ion ratios (IRs) outside ± 20% 
of the expected IR were flagged as being 
out of tolerance and were recoded based on 
their proximity to the LOD; flagged values 
within 10 times the instrumental LOD were 
treated as if they were < LOD and imputed as 
described above, while flagged values greater 
than 10 times the instrumental LOD were 
recoded to missing data.
Total lipid concentration was calculated 
for each subject using measurements of total 
cholesterol and triglycerides in an additional 
0.1 mL serum (Phillips et al. 1989). Masked 
quality control samples, including single 
samples from a large pool and pairs of repli-
cate samples, were interspersed among study 
samples to assess intra  batch and inter  batch 
variability. Case–control matched pairs were 
included in the same batch.
Statistical analysis. All measures were 
adjusted for total lipids (Phillips et al. 1989). 
Analytes with measurements < LOD or flagged 
as out of tolerance in at least half the subjects 
(PCBs 87, 149, and 151) were excluded from 
further analysis. Analyses were conducted for 
individual analytes, total chlordanes (hepta-
chlor epoxide, oxy  chlordane, trans-nonachlor), 
total PCBs, and a priori groupings of PCB 
congeners based on degree of chlorination, 
predicted enzyme induction, and estrogenic-
ity (McFarland and Clarke 1989; Wolff et al. 
1997). Concentrations of total chlordanes 
and PCB groupings were calculated by sum-
ming the concentrations of all relevant analytes 
(including those < LOD). For the calculation 
of groupings, analyte missing values for cases 
and controls were imputed from control meas-
urement data using the previously described 
imputation procedure, with the exception that 
the LOD was specified as the lower limit for 
imputed values.
Intrabatch coefficients of variation (CV) 
were < 10 for most analytes (median 7; range, 
4–21; see Supplemental Material, Table 1, 
available online (doi:10.1289/ehp.0800359.
S1 via http://dx.doi.org/). Interbatch CVs 
were considerably larger (median 37; range, 
17–165). To assess the impact of possibly 
problematic assay batches on our results, we 
reviewed the values of samples from a qual-
ity control (QC) pool, one sample of which 
was included in every batch. For each analyte, 
we identified batches for which the QC pool 
measurement was extreme (± 2 SDs from the 
QC pool mean across all batches) and reran 
our analyses with these batches removed. 
When we reanalyzed our data excluding such 
batches, our findings did not change. 
The DDT metabolites were highly corre-
lated, with Spearman correlation coefficients 
≥ 0.7, as were the three chlordane com-
pounds. Two distinct clusters of strong corre-
lation were observed among PCBs, consisting 
of congeners 28–66 and 138–209.
We conducted statistical analyses using 
SAS, version 9.1 (SAS Institute Inc., Cary, NC, 
USA). All tests were two-sided. Comparisons 
in lipid-adjusted organochlorine levels Purdue et al.
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between matched case–control pairs were per-
formed using the Wilcoxon signed-rank test. 
Conditional logistic regression modeling was 
performed to calculate odds ratios (ORs) and 
95% confidence intervals (CIs) relating cat-
egories of lipid-adjusted analyte levels with risk 
of TGCT. The analyte levels were categorized 
into tertiles based on the levels in controls, 
with the lowest tertile used as the reference 
category. Findings from analyses of dichoto-
mized analyte levels, using control medians 
as cut points, yielded similar findings and are 
not presented here. Analyses were also per-
formed to investigate associations with semi-
nomas (n = 34), the major histologic subtype 
of TGCTs observed in our study. Analyses 
restricted to non  seminomas (n = 8) and tumors 
of mixed histology (n = 5) were not performed 
because of the small numbers of such cases.
We performed additional analyses among 
the subset of individuals for whom informa-
tion on height and BMI at blood collection 
was available (34 cases, 37 controls) to assess 
whether adjustment for these variables (cate-
gorized using control tertiles as cut points) as 
model covariates led to changes in observed 
associations with OC compounds.
Results
The mean age at blood draw among TGCT 
cases and controls was 33.7 years (range, 
20–48) and 33.9 years (21–48), respectively. 
The mean age at diagnosis for cases was 
44.3 years (27–62), with an average length of 
follow-up to diagnosis of 10.7 years (1–27). 
Thirty-four of the 49 cases were seminomas, 
8 were non  seminomas, 5 were of mixed his-
tology, and 2 were of unknown histology.
Results for case–control comparisons of 
lipid-adjusted concentrations of OC insecti-
cide compounds are summarized in Table 1. 
We observed suggestive evidence of an associa-
tion with p,p´-DDE (pWilcoxon = 0.07). Two 
chlordane metabolites were also associated 
with increased risk of TGCT at a borderline 
level of statistical significance: oxychlordane 
and trans-nonachlor (pWilcoxon = 0.05 and 0.07, 
respectively). No association with heptachlor 
epoxide was observed (pWilcoxon = 0.18). The 
summed concentration of all three chlordane 
compounds was significantly greater among 
cases than controls (pWilcoxon = 0.048). The 
other OC insecticide compounds (o,p´-DDT, 
p,p´-DDT, β-HCH, dieldrin, γ-HCH, HCB, 
and mirex) were not found to be associated 
with TGCT (pWilcoxon ≥ 0.10).
Results for analyses of PCBs are summa-
rized in Table 2. The summed concentration 
of all PCB congeners was not associated with 
TGCT (pWilcoxon = 0.17), although associations 
were observed for PCBs 99, 138, 167, and 183 
(pWilcoxon = 0.04, 0.06, 0.02 and 0.07, respec-
tively. Results for all congeners are available in 
Supplemental Material, Table 2 (doi:10.1289/
ehp.0800359.S1). Analyses of most PCB 
groupings were null, although borderline statis-
tically significant associations were observed for 
congeners with a mixed-type pattern of cyto-
chrome p450 induction (pWilcoxon = 0.07).
Findings from analyses investigating asso-
ciations with seminoma are summarized in 
Table 3 [results for all compounds are avail-
able in Supplemental Material, Table 2 
(doi:10.1289/ehp.0800359.S1)]. We observed 
evidence of association with p,p´-DDE and 
oxychlordane (pWilcoxon = 0.06 and 0.006, 
respectively), but not with trans-nonachlor or 
total chlordanes. Although no association with 
total PCBs was observed, several congeners 
were associated with seminoma. Compared 
with controls, seminomas had significantly 
lower concentrations of PCBs 44, 49, and 52 
(pWilcoxon = 0.003, 0.03, and 0.03, respec-
tively) and significantly higher concentrations 
of PCBs 99, 138, 153, 167, 183, and 195 
(pWilcoxon = 0.01, 0.02, 0.04, 0.008, 0.01, and 
0.04, respectively). Four PCB groupings were 
associated with an increased risk of seminoma 
[moderate chlorination, pWilcoxon = 0.04; 
mixed-type induction, pWilcoxon = 0.03; 
Wolff 2 and 2B groupings (Wolff et al. 1997), 
pWilcoxon = 0.05 and 0.04, respectively], 
whereas the Wolff 1A grouping was associ-
ated with reduced risk (pWilcoxon = 0.004). We 
did not perform analyses restricted to cases of 
nonseminoma or mixed histology because of 
the small number of cases.
Our findings did not meaningfully change 
when we repeated our analyses excluding three 
cases diagnosed within the first 2 years of 
follow-up (results not shown). The observed 
associations with OC compounds remained 
upon additional model adjustment for BMI 
and height within the subset of individuals for 
whom these covariate data were available. 
Discussion
In this nested case–control investigation of 
OC compounds and TGCT risk, we observed 
elevated prediagnostic serum concentrations 
oxychlordane, trans-nonachlor, and p,p´-DDE 
among TGCT cases compared with controls. 
We also observed significantly higher levels 
of PCBs 99, 138, 153, 167, 183, and 195 
among seminoma cases versus controls as well 
as significantly lower levels than controls of 
PCBs 44, 49, and 52.
Chlordane is a cyclodiene insecticide com-
monly used in agriculture and termite con-
trol from 1945 until around 1970, at which 
time countries began banning or restricting its 
use. (Norway instituted a ban in 1968.) Our 
finding that TGCT cases had higher levels 
of oxychlordane and trans-nonachlor than 
controls offers further support to previously 
published evidence suggesting that chlordanes 
affect the risk of TGCT development. We 
observed a particularly strong and statistically 
significant association with oxychlordane for 
Table 1. Serum concentration of selected organochlorine insecticide compounds and risk of TGCTs.
Lipid-adjusted analyte concentration (ng/g lipid) ORs for concentration tertiles (reference group: tertile 1)
Cases (n = 49) Controls (n = 51) Tertile 1 Tertile 2 Tertile 3
Analyte Median (range) Median (range) pWilcoxon
a nCo/nCa nCo/nCa OR (95% CI)b nCo/nCa OR (95% CI)
DDT metabolite
o,p’-DDT 20.7 (6.0–220.5) 16.6 (0.3–171.9) 0.36 17/16 17/11 0.8 (0.2–2.6) 17/21 1.4 (0.4–4.5)
p,p’-DDT 226.0 (92.2–584.1) 194.6 (29.3–661.0) 0.23 17/11 17/20 2.3 (0.7–7.2) 17/18 2.1 (0.6–7.2)
p,p’-DDE 2098.5 (750.0–9512.2) 1833.2 (224.9–7436.3) 0.07 17/11 17/18 1.8 (0.6–5.5) 17/20 2.2 (0.7–6.5)
Chlordane
Heptachlor epoxide 12.0 (0.1–43.6) 11.9 (0.2–27.4) 0.18 16/12 16/16 1.7 (0.5–5.8) 16/20 2.4 (0.6–9.1)
Oxychlordane 13.4 (0.6–77.4) 11.8 (0.8–79.4) 0.05 16/11 15/20 3.0 (0.8–11.1) 15/18 3.2 (0.6–16.8)
trans-Nonachlor 23.2 (10.7–76.9) 20.5 (8.3–99.2) 0.07 17/10 17/21 3.1 (0.8–11.6) 17/18 2.6 (0.7–8.9)
Total 47.3 (17.9–143.2) 45.2 (19.0–206.0) 0.048 17/13 17/17 1.8 (0.5–6.5) 17/19 2.3 (0.6–7.2)
Other insecticide
β-HCH 143.0 (58.4–414.0) 129.7 (59.7–295.9) 0.20 17/15 17/13 1.0 (0.4–2.7) 17/21 1.8 (0.5–6.1)
Dieldrin 54.2 (0.6–177.9) 54.7 (0.7–251.0) 0.46 17/11 17/22 3.3 (0.8–12.7) 17/15 2.1 (0.5–9.5)
γ-HCH 6.4 (0.1–42.4) 6.8 (0.2–45.1) 0.89 17/17 17/15 1.0 (0.3–3.1) 17/17 1.1 (0.2–5.0)
HCB 713.4 (199.5–2458.2) 568.6 (168.6–3185.9) 0.26 17/15 17/13 1.1 (0.3–3.7) 17/21 2.9 (0.5–15.2)
Mirex 1.7 (0.1–26.0) 1.5 (0.1–14.9) 0.10 17/16 16/13 0.9 (0.3–2.9) 16/17 1.2 (0.4–3.0)
Abbreviations: nCa, number of cases; nCo, number of controls.
ap-Value from Wilcoxon signed-rank test of matched case–control sets. bORs and 95% CIs calculated from conditional logistic regression of matched case–control sets.Organochlorines and testicular germ cell tumors
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seminoma cases. In the STEED study, sta-
tistically significant associations with TGCT 
were observed for cis-nonachlor and trans-
nonachlor, whereas oxychlordane was asso-
ciated with seminoma risk (McGlynn et al. 
2008). A significant association with cis-non-
achlor was also observed in the Swedish study 
(Hardell et al. 2003). In addition, the case 
mothers in that study had significantly higher 
levels of cis-nonachlor, trans-nona  chlor, and 
the sum of chlordanes compared with control 
mothers, suggesting that the ante  natal period 
may be a particularly important time window 
of exposure for influencing TGCT develop-
ment. No associations with chlordane conge-
ners were observed in the Washington State 
study (Biggs et al. 2008). The biologic basis 
for a chlordane effect on TGCT develop  ment 
is unclear. High doses of chlordane have been 
reported to have deleterious effects on tes-
ticular tissues, with reductions observed in 
testis weight, seminiferous tubule diameter, 
and spermatogenesis (Al-Omar et al. 2000; 
Balash et al. 1987). Findings from in vitro 
studies suggest that the influence of chlordane 
on sex hormone signaling may be complex. 
There is evidence that chlordane is a weak 
agonist for human estrogen receptors α and β 
(Kojima et al. 2004; Lemaire et al. 2006) and 
a weak antagonist for the human androgen 
receptor (Kojima et al. 2004; Lemaire et al. 
2004). However, chlordane may also exert 
anti  estrogenic effects by inhibiting aromatase 
activity through estrogen-related receptor α1 
antagonism (Yang and Chen 1999).
p,p´-DDE is the primary metabolite 
of the first modern synthesized insecticide, 
DDT. DDT was widely used in agriculture 
and vector control in the mid- to late 20th 
century until concerns regarding its environ-
mental persistence and possible health effects 
led several developed countries to ban its use 
in the 1970s and 1980s (including Norway, 
in 1970). Our observed association with 
p,p´-DDE is consistent with findings from the 
STEED study, the largest and only other pro-
spective study of OC compounds and TGCTs 
(McGlynn et al. 2008). No associations with 
this compound were observed in the case–
control studies conducted in Washington 
State (Biggs et al. 2008) and Sweden (Hardell 
et al. 2003), although the latter study, with 
its small size, was underpowered to detect 
associations of moderate magnitude. Research 
suggests that high exposure to p,p´-DDE may 
increase TGCT risk through the induction of 
anti  androgenic effects, as this compound has 
been shown to be a competitive antagonist for 
the androgen receptor (Danzo 1997; Kelce 
et al. 1995; Xu et al. 2006).
Considerable interest has focused on the 
possible health effects of PCBs, a class of OC 
compounds used widely in the manufactur-
ing of electrical equipment and other indus-
trial applications until the institution of bans 
in the 1970s (banned in Norway in 1980). 
Experimental evidence suggests that some 
PCBs may exert estrogenic and possibly anti-
androgenic effects and induce cytochrome 
p450 activity (Bonefeld-Jorgensen et al. 
2001; DeCastro et al. 2006; Portigal et al. 
2002; Soto et al. 1995; Wolff et al. 1997). 
In our study, we did not observe a clear asso-
ciation between PCB levels and TGCT risk. 
However, seminoma cases had significantly 
elevated concentrations of PCBs 99, 138, 153, 
167, 183, and 195 compared with controls. 
We also observed that seminoma cases had 
significantly lower levels of PCBs 44, 49, and 
52 than controls. The associations with semi-
noma risk observed for the moderate chlori-
nation, mixed-type induction, and Wolff 1A, 
2 and 2B groupings appear to reflect the asso-
ciations with the aforementioned congeners.
We are not aware of any clear biologic 
basis for the observed differences in the direc-
tion of association with seminoma risk for 
these two groups. In fact, members of each 
group (PCBs 99, 138, 153, 183, 44, 49, and 
52) have demonstrated similar biologic effects, 
Table 2. Serum concentration of selected PCB congeners and PCB groupings and risk of TGCTs.
Lipid-adjusted analyte concentration (ng/g lipid) ORs for concentration tertiles (reference group: tertile 1)
Cases (n = 49) Controls (n = 51) Tertile 1 Tertile 2 Tertile 3
Analyte Median (range) Median (Range) pWilcoxon
a nCo/nCa nCo/nCa OR (95% CI)b nCo/nCa OR (95% CI)
Selected PCB congenerc
44 16.4 (0.5–92.4) 16.9 (0.6–108.3) 0.14 17/18 16/12  0.4 (0.1–2.5) 17/18 0.6 (0.1–3.8)
49 9.8 (0.4–81.7) 10.9 (0.2–79.2) 0.41 17/16 17/13 0.7 (0.1–3.4) 17/20 1.2 (0.2–7.6)
52 24.4 (3.7–103.4) 23.2 (5.3–116.9) 0.49 17/18 17/10 0.6 (0.2–1.9) 17/20 1.0 (0.3–3.5)
99 68.5 (35.0–408.4) 62.6 (24.2–183.4) 0.04 17/9 17/19 2.2 (0.7–7.3) 17/21 2.2 (0.8–5.9)
138 199.6 (87.2–891.7) 177.3 (79.9–394.5) 0.06 17/15 17/10 0.7 (0.3–2.0) 17/24 1.8 (0.6–5.1)
153 431.5 (166.0–1922.5) 399.3 (187.1–860.7) 0.10 17/16 17/14 0.9 (0.3–2.5) 17/19 1.2 (0.4–3.4)
167 11.2 (0.6–45.0) 9.1 (0.1–24.3) 0.02 16/10 16/13 2.2 (0.5–9.2) 16/19 4.4 (1.0–19.8)
183 30.4 (13.2–151.5) 27.6 (11.1–59.0) 0.07 17/14 16/15 1.0 (0.4–2.6) 16/18 1.3 (0.5–3.5)
195 7.9 (0.2–43.4) 6.9 (0.3–17.6) 0.19 16/10 16/20 1.9 (0.7–5.0) 15/15 1.7 (0.6–4.6)
Total PCBsd 1845.4 (1014.8–8542.7) 1751.1 (800.5–3470.0) 0.17 17/14 17/16 1.1 (0.5–2.7) 17/19 1.3 (0.5–3.8)
Degree of chlorinatione
Low 308.1 (56.9–1753.9) 291.2 (70.4–1335.5) 0.89 17/13 17/17 1.7 (0.5–6.5) 17/19 2.2 (0.4–10.9)
Moderate 1348.7 (596.8–6955.4) 1295.2 (557.8–2866.2) 0.10 17/13 17/16 1.2 (0.5–2.8) 17/20 1.5 (0.6–4.1)
High 87.5 (35.6–722.2) 83.7 (31.6–202.1) 0.42 17/15 17/11 0.7 (0.3–1.8) 17/23 1.4 (0.6–3.3)
Mixed-function oxidase inductionf
Phenobarbital type 918.2 (412.2–4786.9) 880.5 (404.0–1876.6) 0.16 17/12 17/18 1.3 (0.6–3.0) 17/19 1.5 (0.5–4.1)
Mixed type 451.0 (218.6–2112.1) 426.7 (170.7–919.1) 0.07 17/13 17/14 1.1 (0.4–2.7) 17/22 1.7 (0.6–4.8)
Wolff groupg
1 172.9 (113.3–846.1) 166.2 (70.6–450.5) 0.22 17/13 17/18 1.4 (0.5–3.9) 17/18 1.4 (0.5–3.9)
1A 51.0 (6.7–275.8) 53.6 (8.8–304.4) 0.32 17/18 17/10 0.4 (0.1–1.7) 17/21 1.0 (0.2–4.4)
1B 118.9 (49.8–742.3) 109.4 (42.0–332.9) 0.15 17/10 17/19 1.8 (0.7–5.0) 17/20 1.8 (0.7–4.8)
2 531.2 (278.0–2458.0) 493.9 (210.4–1021.6) 0.10 17/13 17/13 1.0 (0.4–2.3) 17/23 1.6 (0.6–4.1)
2A 229.7 (115.8–1037.9) 203.8 (89.3–603.7) 0.16 17/13 17/14 1.4 (0.4–4.3) 17/22 1.9 (0.6–5.6)
2B 297.3 (130.3–1420.1) 275.8 (121.1–581.6) 0.10 17/15 17/13 0.9 (0.4–2.2) 17/21 1.4 (0.5–3.7)
3 784.2 (312.5–3985.0) 738.8 (333.9–1599.8) 0.13 17/13 17/18 1.3 (0.5–3.1) 17/18 1.3 (0.5–3.8)
Abbreviations: nCa, number of cases; nCo, number of controls.
ap-Value from Wilcoxon signed-rank test of matched case–control sets. bORs and 95% CIs calculated from conditional logistic regression of matched case–control sets. cCongeners 
significantly associated with TGCTs or seminoma (Table 3) reported. Results for all congeners are provided in Supplemental Material, Table 2 (doi:10.1289/ehp.0800359.S1). dSum of all 
31 congeners included in the analysis. eLow: PCBs 11, 18, 28, 44, 49, 52, 66, and 74; moderate: PCBs 99, 105, 110, 118, 128, 138, 146, 153, 156, 157, 167, 170, 172, 177, 178, 180, 183, 187, and 
189; high: PCBs 194, 195, 196, 201, 206, and 209. fPhenobarbital-type induction: PCBs 11, 52, 66, 99, 146, 153, 180, 183, 194, 195, 196, 206, and 209; mixed-type induction: PCBs 105, 118, 128, 
138, 156, 157, 167, 170, and 189. gWolff 1A: PCBs 44, 49, and 52; Wolff 1B: PCBs 177, 187, and 201; Wolff 2A: PCBs 66, 74, 105, 118, 156, and 167; Wolff 2B: PCBs 128, 138, and 170; Wolff 3: 
PCBs 99, 153, 180, 183, and 196.Purdue et al.
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namely, phenobarbital-type cytochrome p450 
induction activity and estrogenicity. (Bonefeld-
Jorgensen et al. 2001; DeCastro et al. 2006; 
Wolff et al. 1997). The only other published 
findings regarding PCBs and TGCTs come 
from the Swedish case–control study (Hardell 
et al. 2003, 2004); in that study, no difference 
in PCB levels between cases and controls was 
observed. In maternal comparisons, however, 
mothers of seminoma and non  seminoma cases 
had significantly higher levels of total PCBs 
and several individual congeners, including 
PCBs 99, 138, 153, 183, and 195 (PCB 167 
was not measured). Maternal levels of PCB 52 
were not found to be associated with reduced 
cancer risk (PCBs 44 and 49 were not meas-
ured). In summary, the published epidemio-
logic evidence, although limited, suggests that 
some PCB congeners may be associated with 
TGCT risk. 
An important strength of this study is the 
use of serum samples collected prior to diag-
nosis, thus eliminating the possibility that 
our measurements were affected by the dis-
ease state. Given the rarity and young age 
at onset of TGCTs, most cohort studies are 
not feasible for investigations of this cancer. 
The Janus cohort is one of the few cohorts 
in the world with a large enough number of 
subjects recruited as young adults and with 
stored serum to make prospective serologic 
investigations of TGCTs feasible. Moreover, 
the time period during which the samples 
were collected (1972–1978) is particularly 
relevant for studying the health effects of OC 
compounds, as these chemicals were still in 
use or had only recently been banned at the 
time of collection. 
The most notable limitation of this study 
is its small sample size, which greatly limited 
the statistical power to detect associations of 
moderate magnitude. As a consequence, we 
cannot rule out the existence of modest effects 
on TGCT risk from among the other investi-
gated OC compounds. In addition, given the 
large number of measured compounds and 
generally borderline significance level of our 
observed findings, we cannot rule out the pos-
sibility that some of the observed associations 
may have arisen due to chance, although it is 
worth noting that associations with oxychlor-
dane, trans-nonachlor, and p,p´-DDE have 
been previously reported. Moreover, some of 
the observed associations may have resulted 
from the moderate to strong correlations 
between many compounds. Finally, we were 
unable to investigate the relative importance 
of specific time windows of exposure to OC 
compounds, most notably the antenatal and 
early childhood periods, on TGCT risk. 
The mean age at diagnosis and propor-
tion of cases with seminoma histology in 
this study were higher than those observed 
in population-based cancer registries. This is 
likely a reflection of the older age distribu-
tion of cohort participants at baseline relative 
to the general population. Nonetheless, the 
seminoma findings should be interpreted with 
caution, in light of their small sample size and 
Table 3. Serum concentration of selected organochlorine compounds and risk of seminoma tumors.
Median lipid-adjusted analyte 
concentration (ng/g lipid) ORs for concentration tertiles (reference group: tertile 1)a
Seminoma Controls Tertile 1 Tertile 2 Tertile 3
Analyte (n = 34) (n = 34) pWilcoxon
b nCo/nCa nCo/nCa OR (95% CI)c nCo/nCa OR (95% CI)
Selected organochlorine insecticide
p,p’-DDE 2100.4 1768.2 0.06 12/10 13/10 1.0 (0.3–3.8) 9/14 2.2 (0.5–8.7)
Oxychlordane 14.3 11.8 0.006 10/6 13/15 3.2 (0.6–15.7) 9/13 5.1 (0.7–36.8)
trans-Nonachlor 22.6 19.6 0.21 13/9 10/15 3.7 (0.7–19.0) 11/10 1.6 (0.4–6.0)
Total chlordanes 45.4 45.2 0.13 11/9 12/12 1.4 (0.3–5.5) 10/12 1.6 (0.4–6.6)
PCB
Total PCBsd 1819.7 1856.6 0.12 10/9 11/11 1.1 (0.4–3.3) 13/14 1.2 (0.4–4.1)
Selected PCB congenere
44 15.0 17.0 0.003 9/13 9/9 0.3 (0.03–3.0) 15/12 0.2 (0.01–2.0)
49 9.5 11.6 0.03 10/12 10/8 0.3 (0.02–3.0) 14/14 0.3 (0.02–4.7)
52 23.1 26.8 0.03 10/14 10/6 0.3 (0.05–1.6) 14/14 0.4 (0.07–2.3)
99 75.4 63.5 0.01 12/5 10/12 5.6 (0.9–36.3) 12/17 4.4 (1.0–20.5)
138 203.3 177.2 0.02 11/9 12/8 0.9 (0.3–3.0) 11/17 2.1 (0.6–7.2)
153 439.3 395.9 0.04 12/10 9/11 1.4 (0.4–4.7) 13/13 1.2 (0.4–4.3)
167 11.9 8.9 0.008 11/6 12/8 2.3 (0.4–13.4) 10/15 6.7 (1.1–42.9)
183 31.9 27.4 0.01 10/8 14/11 1.0 (0.3–3.5) 8/14 2.9 (0.6–13.7)
195 8.3 7.1 0.04 9/6 13/13 2.0 (0.5–7.2) 8/13 3.0 (0.8–11.7)
Degree of chlorinationf
Low 309.9 291.6 0.46 11/10 8/11 2.3 (0.4–14.1) 15/13 0.5 (0.04–5.4)
Moderate 1421.8 1289.6 0.04 10/8 12/11 1.2 (0.4–3.4) 12/14 1.5 (0.4–5.4)
High 98.5 85.0 0.28 11/11 13/6 0.4 (0.1–1.5) 10/17 1.9 (0.6–5.9)
Mixed-function oxidase inductiong
Phenobarbital type 935.1 882.0 0.10 11/8 11/12 1.4 (0.5–3.8) 12/14 1.6 (0.5–5.8)
Mixed type 465.4 424.4 0.03 11/8 11/10 1.3 (0.4–3.9) 12/16 2.0 (0.6–6.9)
Wolff grouph
1 172.2 178.8 0.53 10/11 11/11 0.9 (0.2–3.3) 13/12 0.8 (0.2–3.1)
1A 49.3 54.0 0.004 10/14 9/7 0.3 (0.1–1.8) 15/13 0.3 (0.04–1.9)
1B 128.4 111.8 0.08 11/8 11/9 1.0 (0.3–3.3) 12/17 1.9 (0.6–6.0)
2 551.3 497.3 0.05 11/8 11/8 1.0 (0.3–3.5) 12/18 1.9 (0.6–5.9)
2A 243.4 207.0 0.12 12/10 10/7 1.0 (0.2–3.9) 12/17 1.6 (0.5–5.4)
2B 303.7 273.6 0.04 11/8 12/10 1.1 (0.4–3.2) 11/16 2.4 (0.6–8.8)
3 791.8 719.0 0.07 12/8 11/13 1.6 (0.5–4.7) 11/13 1.8 (0.5–6.6)
Abbreviations: nCa, number of cases; nCo, number of controls.
aCategory cut points are the same as those used in Tables 1 and 2. bp-Value from Wilcoxon signed-rank test of matched case–control sets. cORs and 95% CIs calculated from con-
ditional logistic regression of matched case–control sets. dSum of all 31 congeners included in the analysis. eResults for all analytes are provided in Supplemental Material, Table 3 
(doi:10.1289/ehp.0800359.S1). fLow: PCBs 11, 18, 28, 44, 49, 52, 66, and 74; moderate: PCBs 99, 105, 110, 118, 128, 138, 146, 153, 156, 157, 167, 170, 172, 177, 178, 180, 183, 187, and 189; high: 
PCBs 194, 195, 196, 201, 206, and 209. gPhenobarbital-type induction: PCBs 11, 52, 66, 99, 146, 153, 180, 183, 194, 195, 196, 206, and 209; mixed-type induction: PCBs 105, 118, 128, 138, 156, 
157, 167, 170, and 189. hWolff 1A: PCBs 44, 49, and 52; Wolff 1B: PCBs 177, 187, and 201; Wolff 2A: PCBs 66, 74, 105, 118, 156, and 167; Wolff 2B: PCBs 128, 138, and 170; Wolff 3: PCBs 99, 
153, 180, 183, and 196 (Wolff et al. 1997).Organochlorines and testicular germ cell tumors
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the fact that they were not the primary end 
point of this study.
In conclusion, this study provides addi-
tional but qualified epidemiologic evidence 
that serum levels of p,p´-DDE, oxychlordane, 
and trans-nonachlor compounds—and more 
speculatively, some PCB congeners (44 and 
167 in particular)—may be associated with 
risk of TGCTs, including seminomas. These 
chemicals, although long banned in devel-
oped countries, are still a concern because 
of their continued presence in certain food 
sources (Fattore et al. 2006; Freijer et al. 
2001; Schecter et al. 2001) and the continued 
use of OC pesticides in developing countries 
(Gorman and Tynan 2003; Mathur 1993; 
Santilo et al. 1997). Additional investigations 
into the relationship between TGCTs and 
exposure to OC compounds, particularly in 
early life, are warranted. 
cO r r e c t i O n
Many values in the original version pub-
lished online were incorrect, especially in 
the tables. Also, “oxychlordane” was incor-
rectly called “oxychlor” in two places in 
the “Discussion.” These errors have been 
corrected here.
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